NCT06615713

Brief Summary

The purpose of the study is to assess safety and efficacy of a novel steerable ureteral catheter system, the CVAC System for the treatment of urinary stones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2024

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

April 28, 2026

Completed
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

September 24, 2024

Results QC Date

February 12, 2026

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Stone Clearance (% Reduction in Stone Volume)

    The percent reduction (\[Baseline stone volume- 30-Day stone volume\] / Baseline stone volume) in stone volume following intervention, observed on non-contrast CT (NCCT) (2.0mm slice thickness). A positive result indicates a decrease in stone volume removed during the procedure; a negative value indicates an increase in stone volume following the procedure.

    30 Days

  • Residual Stone Volume (RSV)

    A continuous quantitative measure of remaining stone volume following intervention, observed on non-contrast CT (NCCT) (2.0mm slice thickness).

    30 Days

  • Stone Free Rate (SFR) - Zero Fragments

    Where stone free status is defined as zero residual fragments at 30 days observed on non-contrast CT (NCCT) (2.0mm slice thickness). SFR is calculated by determining the number of kidneys in each treatment arm with a stone free status of zero fragments and dividing that by the total number of kidneys treated in the respective treatment arm.

    30 Days

Study Arms (1)

Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System

EXPERIMENTAL

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Device: Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System

Interventions

The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).

Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate for ureteroscopy with laser lithotripsy;
  • Be willing and able to return for and respond to all study-related follow up procedures; and,
  • Have been informed of the nature of the study and have agreed to the IRB approved informed consent form (ICF).

You may not qualify if:

  • Significant morbidities;
  • Unable to meet the treatment and follow up protocol requirements; and,
  • Ureteral or kidney abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Muljibhai Patel Urological Hospital

Nadiād, India

Location

MeSH Terms

Conditions

NephrolithiasisKidney CalculiUrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Jacqueline Welch
Organization
Calyxo, Inc.

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2024

First Posted

September 27, 2024

Study Start

September 5, 2024

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

April 28, 2026

Results First Posted

April 28, 2026

Record last verified: 2026-04

Locations